Quinolinic Acid May Have Role in AIDS Dementia Complex CDC Daily UpdateImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Quinolinic Acid May Have Role in AIDS Dementia Complex

Reuters Health Information Services (12/22/97)


Abstract: In the December issue of Neurology, researchers from Australia's St. Vincent's Hospital report that in vitro studies suggest that quinolinic acid--a neurotoxic tryptophan metabolite that is a byproduct of the kynurenine pathway--is involved in AIDS-related dementia and, therefore, neuroprotective methods may be effective in the treatment of the disease. After adding 6-Chloro-D-tryptophan (6CDT)--a quinolinic acid biosynthesis inhibitor--to half of the test cultures from a patient with AIDS dementia, the doctors noted that 6CDT reduced the neurotoxicity of HIV-1 infected macrophage supernatants. Based on the data, the research team concluded that the kynurenine pathway may be important in AIDS -related dementia and that strategies to inhibit it may be effective against the disease.


971224
AD972344


Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.